Cell Therapy Market Size Worth $28.5 billion by 2026 - KBV Research
The Global Cell Therapy Market size is expected to reach $28.5 billion by 2026, rising at a market growth of 26.2% CAGR during the forecast period.

(firmenpresse) - According to a new report Global Cell Therapy Market, published by KBV research, The Global Cell Therapy Market size is expected to reach $28.5 billion by 2026, rising at a market growth of 26.2% CAGR during the forecast period.
The clinical-use segment would exhibit a considerable rate during the forecast period due to the low penetration of this segment. Though, some cell therapies received approval for clinical applications like CARTISTEM, Invossa, MACI, Epicel, Cellgram-AMI, Cupistem, Cellistem IC, GINTUIT, Prochymal, and Imlygic, which would motivate the companies to put investment in this segment.
In 2019, the Allogeneic therapies segment procured the notable share of the cell therapy market. the segment would showcase a similar trend throughout the forecast period. This is owing to the various benefits with respect to the Allogeneic transplants like high availability, no requirement to recognize an HLA-matched donor, less risk of chronic complications, no risk of GVHD, and no requirement for immunosuppressive therapy. Moreover, Allogeneic therapies are less costly in comparison to allogenic therapies which can be further supporting the segment growth.
North America dominated the market in 2019. In Asia-Pacific, the cell therapy market would exhibit a promising growth rate during the forecast period. The increasing funding by the developers and consumers in educating themselves for the latest medicinal therapies would fuel the revenue generation of the emerging countries of the region. There are various stem cell consortiums in Asian Countries, which plan to ensure ordinated and organized R&D activities. In addition, patients from western countries are witnessed to move to Asian countries for treatment, due to the adaptable legal framework.
Full Report: https://www.kbvresearch.com/cell-therapy-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fujifilm Holdings Corporation, Smith & Nephew PLC, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Medipost Co., Ltd., Stemedica Cell Technologies, Inc., NuVasive, Inc., Avantor, Inc., Vericel Corporation, and Pharmicell Co., Ltd.
Global Cell Therapy Market Segmentation
By Therapy Type
Autologous
Allogeneic
By Therapeutic Area
Malignancies
Autoimmune Disorders
Musculoskeletal Disorders
Dermatology
Others
By End User
Academic & Research Institutes
Hospitals & Clinics
By Cell Type
Stem Cell
Umbilical Cord-Derived
Adipose-Derived Stem Cell
Non-Stem Cell
Bone Marrow
Blood
Others
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Companies Profiled
Fujifilm Holdings Corporation
Smith & Nephew PLC
Kolon TissueGene, Inc.
JCR Pharmaceuticals Co., Ltd.
Medipost Co., Ltd.
Stemedica Cell Technologies, Inc.
NuVasive, Inc.
Avantor, Inc.
Vericel Corporation
Pharmicell Co., Ltd.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Knowledge Based Value (KBV) Research is a global brand
Datum: 23.04.2021 - 11:20 Uhr
Sprache: Deutsch
News-ID 635176
Anzahl Zeichen: 4024
contact information:
Contact person: KBV Research
Town:
New York
Phone: +1 (646) 661-6066
Kategorie:
Health & Nutrition
Typ of Press Release: Personel
type of sending: don't
Date of sending: 23Cell Therapy Market Size Worth $28.5 bil/04/2021
Diese Pressemitteilung wurde bisher 579 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cell Therapy Market Size Worth $28.5 billion by 2026 - KBV Research"
steht unter der journalistisch-redaktionellen Verantwortung von
KBV Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).